Trial intelligence / Profile preview

Sex hormone administration effects on marrow and visceral adiposity

NL-OMON25190Recruiting

Sponsor
Amsterdam University Medical Center
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of estradiol, testosterone and cyproterone (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in vertebral marrow fat fraction, Change in visceral fat by MRI and 1 more. Started Feb 2019; status: recruiting.

02

Drugs

estradioltestosteronecyproterone

Beyond the preview

Go deeper on NL-OMON25190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call